France· FR:60456535
AGYRAX, comprimé sécable
A medicinal product, registered in France by MEDIXAL, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Manufacturer
- MEDIXAL
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400933488383plaquette(s) thermoformée(s) PVC-aluminium de 15 comprimé(s)EUR 1.92
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
AGYRAX in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBONINEWellSpring Pharmaceutical Corporation
- SpainCHICLIDA 25 mg CHICLES MEDICAMENTOSOSFleer Española S.L.
- FinlandPostafenParanova Oy
- BelgiumAgyrax 25 mgMediXal
- United KingdomSea-Legs 12.5mg tabletsG.R. Lane Health Products Ltd
- NorwayAgyrax2care4 ApS
- NetherlandsSuprimal, tabletten 12,5 mgRemark Pharma
- SwedenPostafen 25 mg TablettCampus Pharma AB
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Belgium · Agyrax, Postafene
- Denmark · Postafen
- Spain · Chiclida
- Finland · Postafen
- United Kingdom (Northern Ireland) · Sea-Legs, Traveleeze
- Greece · Emetostop
- Iceland · Postafen
- Luxembourg · Agyrax, Postafene
- Netherlands · Suprimal
- Norway · Postafen
- Sweden · Postafen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fa93fb19-6f13-40f2-b906-c728051e4382 GET /v1/drugs/fa93fb19-6f13-40f2-b906-c728051e4382?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60456535",
"date_amm": "1992-05-20",
"type_amm": "Procédure nationale",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé sécable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about AGYRAX.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.